Medication info
Rovast 10 mg (Rosuvastatin Calcium)

Rovast 10 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Hanpoong Pharm Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201904551 · Approved 2019.07.04 · Insurance code 658106570

Summary

Main use
Improves dyslipidemia, inhibits the progression of atherosclerosis, and reduces the risk of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg per day. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Hanpoong Pharm Co., Ltd.

Efficacy & effects

Improves dyslipidemia, inhibits the progression of atherosclerosis, and reduces the risk of cardiovascular disease

  • Hypercholesterolemia
  • Heterozygous familial hypercholesterolemia
  • Mixed dyslipidemia
  • Homozygous familial hypercholesterolemia
  • Dysbetalipoproteinemia
  • Risk of stroke
  • Risk of myocardial infarction
  • Risk of arterial revascularization
View approved original text

This medicine is used as an adjunct to diet and exercise in patients with primary hypercholesterolemia and mixed dyslipidemia when these are not adequate for control. It is also helpful in patients with homozygous familial hypercholesterolemia along with other lipid-lowering therapies. It is effective in lowering total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. For pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia, it is also used as an adjunct to diet to contribute to reducing cholesterol levels. It is also utilized as an adjunct to diet in patients with primary dysbetalipoproteinemia. Furthermore, it helps decrease the risk of stroke, myocardial infarction, and arterial revascularization in middle-aged and older patients with elevated high-sensitivity C-reactive protein levels and other cardiovascular risk factors. In summary, this medicine is used for various dyslipidemias and to reduce cardiovascular disease risk.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg per day. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medicine should not be used in certain patients. For example, it should not be administered to patients who are allergic to this drug, have severe liver dysfunction, have muscle diseases, take specific immunosuppressants, have severe kidney dysfunction, are pregnant or breastfeeding, or have genetic issues such as lactose intolerance. Additionally, as this medicine can affect the liver or muscles, it should be used cautiously in patients who consume large amounts of alcohol or have a history of liver disease, those with hypothyroidism, those with renal impairment, and elderly patients; regular liver function tests and muscle-related tests should be performed before and during treatment. If symptoms such as muscle pain, weakness, fatigue, or warmth occur, medical personnel should be informed immediately, and if these symptoms are severe or if muscle damage levels increase significantly, discontinuation of the drug should be considered. This medicine can interact with other medications, so caution is needed when taken with certain antiviral drugs, immunosuppressants, antibiotics, and fibrate class drugs, as the risk of muscle damage may increase with concurrent use. Women who are pregnant or planning to become pregnant must consult with healthcare providers before taking this medicine and should use appropriate contraception. Breastfeeding should also be avoided, as use during pregnancy or nursing can pose risks to the fetus or infant. In case of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored. Finally, this medicine is known not to significantly affect the ability to drive or operate machinery, but caution is advised due to possible side effects such as dizziness.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, appetite loss, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It should be kept in a location that avoids extreme heat or cold, preferably at a temperature between 1 and 30 degrees Celsius, which is room temperature.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.